Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:761-767
Published online before print July 28, 2003, doi: 10.1161/01.HYP.0000085331.22169.3F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/4/761    most recent
01.HYP.0000085331.22169.3Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Javeshghani, D.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Javeshghani, D.
Right arrow Articles by Schiffrin, E. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Hypertension - basic studies
Right arrow Other Vascular biology

(Hypertension. 2003;42:761.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Attenuated Responses to Angiotensin II in Follitropin Receptor Knockout Mice, a Model of Menopause-Associated Hypertension

Danesh Javeshghani; Rhian M. Touyz; M. Ram Sairam; Agostino Virdis; Mario Fritsch Neves; Ernesto L. Schiffrin

From the Experimental Hypertension (D.J., R.M.T., A.V., M.F.N., E.L.S.) and Molecular Reproduction Research Laboratories (D.J., M.R.S.), Clinical Research Institute of Montreal, Montreal, Ontario, Canada.

Correspondence to Rhian M. Touyz, MD, PhD, Clinical Research Institute of Montreal, Quebec, 110 Pine Ave West, Montreal, H2W 1R7, Canada. E-mail touyzr{at}ircm.qc.ca

Activation of the renin-angiotensin system has been implicated in the development of hypertension in menopausal women. We investigated whether blood pressure is elevated and whether angiotensin II (Ang II)-induced vascular reactivity is increased in follitropin receptor knockout (FORKO) female mice. These mice are estrogen-deficient and have characteristics similar to postmenopausal women. Serum estradiol levels were significantly reduced in FORKO versus wild-type mice (1.4±0.2 versus 15±3 pg/mL, P<0.01). Blood pressure, measured by telemetry, was significantly increased in FORKO (120±2/92±2 mm Hg) compared with wild-type counterparts (110±1/85±2 mm Hg, P<0.05). Vascular dose responses to acetylcholine (endothelium-dependent dilation) and sodium nitroprusside (endothelium-independent dilation) were not different. Ang II–induced vasoconstriction was blunted in FORKO compared with wild-type mice (P<0.05). Media-to-lumen ratio was significantly increased in FORKO (6.2±0.5%) versus control mice (5.2±0.3%), indicating vascular remodeling. Aortic ·O2- levels, NADH-inducible ·O2- generation, and plasma levels of thiobarbituric acid reactive substances (TBARS), indexes of oxidative stress, were not significantly different between wild-type and FORKO mice. Vascular AT1 receptor content, assessed by immunoblotting, was reduced by 40% in FORKO compared with wild-type mice (P<0.01). This was associated with decreased circulating Ang II levels in FORKO versus control mice. These data indicate that FORKO mice have increased blood pressure, vascular remodeling, and attenuated vascular responses to Ang II. Our findings suggest that vascular Ang II signaling is downregulated in female FORKO mice and that Ang II may not play an important role in blood pressure elevation in this model of menopause-associated hypertension.


Key Words: renin-angiotensin system • estrogen • hypertension, experimental • resistance




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. O. Belo, M. R. Sairam, and A. M. dos Reis
Impairment of the Natriuretic Peptide System in Follitropin Receptor Knockout Mice and Reversal by Estradiol: Implications for Obesity-Associated Hypertension in Menopause
Endocrinology, March 1, 2008; 149(3): 1399 - 1406.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Nakayama, N. Kuroi, M. Sano, Y. Tabara, T. Katsuya, T. Ogihara, Y. Makita, A. Hata, M. Yamada, N. Takahashi, et al.
Mutation of the Follicle-Stimulating Hormone Receptor Gene 5'-Untranslated Region Associated With Female Hypertension
Hypertension, September 1, 2006; 48(3): 512 - 518.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T R. Kumar
What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice?
Reproduction, September 1, 2005; 130(3): 293 - 302.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. Reckelhoff
Sex Steroids, Cardiovascular Disease, and Hypertension: Unanswered Questions and Some Speculations
Hypertension, February 1, 2005; 45(2): 170 - 174.
[Full Text] [PDF]


Home page
HypertensionHome page
J. F. Reckelhoff and L. A. Fortepiani
Novel Mechanisms Responsible for Postmenopausal Hypertension
Hypertension, May 1, 2004; 43(5): 918 - 923.
[Abstract] [Full Text] [PDF]